FAQ

We have listed frequently asked questions from our customers. Please check them before making an inquiry.

Q. What kind of business do you conduct?

A. Based on the corporate philosophy of SNBL , we are currently developing three business areas with the aim of "creating a chain of happiness by being close to all stakeholders involved in our company."

1.
CRO business: This isSNBL 's flagship business. We conduct non-clinical studies and clinical trials (clinical trials) necessary for drug development on behalf of pharmaceutical companies. Companies that are contracted with testing by pharmaceutical companies are called CROs (Contract Research Organizations), and we are the first CRO in Japan.

2.
Translational Research (TR) Business: We support the discovery of promising seeds and new technologies from basic research at domestic and international universities and bio-ventures, enhancing their added value and facilitating their commercialization. Additionally, we are engaged in the development of formulations applying our independently developed intranasal administration platform technology.

3.
Social Benefit Creation Business: We are involved in the Medipolis business (hospitality and power generation businesses) as well as research and development for the artificial seed production of glass eels.

Q. What is your approach to corporate governance?

A. In order to further enhance corporate value, the basic policy of SNBL is to realize effective corporate governance by improving the soundness of management, improving efficiency, improving transparency, and strengthening the compliance system. For details Here Please see.

Q. Where can I check past financial information?

A. Our Financial Information Page Please see.

Q. I would like to know more details about dividends.

A. Regarding dividends, Here Please see.

Q. Where can I find information about recruitment?

A. Recruitment page Here Please see.

See more frequently asked questions

Contact form

If the above FAQs do not resolve your issue, please contact us using the form below.
During the silent period, we refrain from responding to questions and inquiries, so we may not be able to answer inquiries received during this period. Depending on the content of the inquiry, we may not be able to respond or it may take time to reply, so please understand in advance. The email response sent from our company is intended for the individual customer. Please refrain from disclosing any part or all of the response content to others without our consent.

    Inquiry Content
    Business Type

    "Important Notice"

    Depending on the content of your inquiry, we may not be able to respond.
    Please note that we refrain from responding to questions that fall under the following categories from IR.

    • Questions regarding non-public information (such as business performance trends)
    • Questions that may fall under 'material facts' as defined in Article 166 of the Financial Instruments and Exchange Act (such as shareholder returns, stock price measures)
    • Questions regarding stock market price movements
    • Messages that constitute slander or defamation
    • Inquiries related to sales, solicitation, or other matters not related to IR
    Name
    Furigana

    ※If you do not wish to disclose your name, please write 'Anonymous.'

    Company name
    telephone number
    E-mail
    How did you hear about SNBL?
    Contents

    "Privacy Policy" Please review it and send it after agreeing.

    Check your input

    Please check to ensure there are no mistakes in the content.

    Inquiry Content
    Business Type
    Name
    Furigana
    Company name
    telephone number
    E-mail
    How did you hear about SNBL?

    Contents